Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Senti Biosciences Inc SNTI

Healthcare Biotechnology
Senti Biosciences, Inc. is a clinical-stage biotechnology company. It is developing cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. It is focused on off-the-shelf CAR-NK cell therapy programs for oncology indications. Its lead product candidate, SENTI-202, is a potential Logic Gated off-the-shelf CAR-NK cell therapy... see more

Bullboard (NDAQ:SNTI)

View:
Post by whytestockson Dec 16, 2024 6:00pm

Senti Bio Announces First Patient Dosed in Clinical Trial of

Just In: $SNTI Senti Bio Announces First Patient Dosed in Clinical Trial of SN301A in Hepatocellular Carcinoma in Collaboration with Celest Therapeutics@ Dose-finding clinical trial in China designed ...more  
22
Post by SkyProfit12on Dec 04, 2024 9:01am

$SNTI Slips, $MYNZ Builds for the Future

$SNTI falls 29% to $7.14 amid concerns in synthetic biology progress. Meanwhile, $MYNZ, post-reverse split, is regaining strength, advancing its focus on molecular diagnostics and showing promise for ...more  
27
Post by 10QKingon Dec 02, 2024 10:10am

SNTI Kaboom!! SPAI News

SNTI Kaboom!! SPAI News
10
Post by whytestockson Dec 02, 2024 10:00am

Senti Biosciences, Inc. Announces Oversubscribed $37.6 Milli

NEWS: $SNTI Senti Biosciences, Inc. Announces Oversubscribed $37.6 Million Private Placement Equity FinancingSOUTH SAN FRANCISCO, Calif., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc ...more  
15
Post by MikeTesteron Aug 02, 2024 10:16am

Senti Biosciences, Inc. (NASDAQ:SNTI): A Promising Gene Circ

https://beyondspx.com/2024/08/01/senti-biosciences-inc-nasdaqsnti-a-promising-gene-circuit-platform-with-significant-potential/
19
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities